Harvard Medical School, Harvard University, Boston, Massachusetts.
McDonough School of Business, Georgetown University, Washington, DC.
JAMA Netw Open. 2023 Jun 1;6(6):e2320694. doi: 10.1001/jamanetworkopen.2023.20694.
Price transparency regulations aim to help patients make informed decisions about medical care, but enforcing these rules is a policy challenge. There may be an association between financial penalties and hospital compliance for enforcing price transparency regulations.
To evaluate the association between financial penalties and acute care hospital compliance with the 2021 Centers for Medicare & Medicaid Services (CMS) Price Transparency Rule.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study uses an instrumental variable design to evaluate the responses of 4377 acute care hospitals in the US operating in 2021 and 2022 to changes in financial penalties in the context of a federal rule requiring hospitals to disclose privately negotiated prices.
Changes in noncompliance penalties between 2021 and 2022 based on a nonlinear function of bed counts.
Whether hospitals publicly posted a machine-readable file with private, payer-specific negotiated prices at the service-code level. Negative controls were used to address confounding.
The final sample included 4377 hospitals. Compliance increased from 70.4% (n = 3082) in 2021 to 87.7% (n = 3841) in 2022, with 90.2% of hospitals (n = 3948) reporting prices in at least 1 year. Noncompliance penalties increased from $109 500/y in 2021 to a mean (SD) of $510 976 ($534 149)/y in 2022. Penalties in 2022 were substantial, averaging 0.49% of total hospital revenue, 0.53% of total hospital costs, and 1.3% of total employee wages. Compliance increases were significantly positively correlated with penalty increases: a $500 000 increase in penalty was associated with a 2.9-percentage point (95% CI, 1.7-4.2 percentage points; P < .001) increase in compliance. Results were robust to controlling for observable hospital characteristics. No associations were found for preperiod (2021) compliance or ranges of bed counts where penalties do not vary.
In this cohort study of 4377 hospitals, compliance with the CMS Price Transparency Rule was associated with increased financial penalties. These findings are relevant for the enforcement of other regulations designed to promote transparency in health care.
价格透明度法规旨在帮助患者做出有关医疗保健的明智决策,但执行这些法规是一个政策挑战。对价格透明度法规的执行进行财务处罚可能与医院的合规性有关。
评估对 2021 年医疗保险和医疗补助服务中心(CMS)价格透明度规则执行情况的医院财务处罚与急性护理医院合规性之间的关联。
设计、地点和参与者:本队列研究使用工具变量设计,评估了美国 2021 年和 2022 年 4377 家急性护理医院对联邦法规的反应,该法规要求医院公布私下协商的价格,以改变财务处罚。
根据床位数量的非线性函数,2021 年至 2022 年非合规性处罚的变化。
是否医院公开公布了一份带有服务代码级别私人、支付方特定谈判价格的机器可读文件。使用负面对照来解决混杂因素。
最终样本包括 4377 家医院。合规性从 2021 年的 70.4%(n=3082)增加到 2022 年的 87.7%(n=3841),90.2%(n=3948)的医院报告了至少 1 年的价格。2021 年的非合规性处罚从每年 109500 美元增加到 2022 年的平均(SD)510976 美元(534149 美元)/年。2022 年的罚款数额很大,平均占医院总收入的 0.49%,占医院总费用的 0.53%,占员工总工资的 1.3%。合规性的增加与罚款的增加呈显著正相关:罚款增加 500000 美元与合规性增加 2.9 个百分点(95%置信区间,1.7-4.2 个百分点;P<.001)相关。结果在控制了可观察的医院特征后仍然稳健。在 2021 年的预期间(合规性)或处罚范围没有变化的床位数量上没有发现相关性。
在这项对 4377 家医院的队列研究中,CMS 价格透明度规则的遵守情况与增加的财务处罚有关。这些发现与旨在促进医疗保健透明度的其他法规的执行有关。